-
CERN upbeat as China halts particle accelerator mega-project
-
2025 on track to tie second hottest year on record: EU monitor
-
Chile to vote for president as hard-right Kast tipped to win
-
Chargers edge reigning champions Eagles after defensive show
-
RSF says Israel killed highest number of journalists again this year
-
Suns, Spurs win in last tuneups for NBA Cup showdowns
-
Hay to debut for New Zealand as Blundell out of 2nd West Indies Test
-
World record winning streak sets up Morocco for AFCON challenge
-
All Blacks face France in first Test at new Christchurch stadium
-
Cambodia and Thailand clash at border as civilian toll rises
-
South Korea police raid e-commerce giant Coupang over data leak
-
Most markets track Wall St losses as jitters set in ahead of Fed
-
Kenya deploys more police officers to control Haiti's gangs
-
Somali TikToker deported from US for spy kidnapping may be innocent
-
Indian pride as Asiatic lions roar back
-
Australia quick Hazlewood ruled out of Ashes after injury setback
-
Major Japan quake leaves 30 injured
-
Rising living costs dim holiday sparkle for US households
-
Data centers: a view from the inside
-
Long-serving Russian envoy to North Korea dies
-
Reddit says Australia's under-16 social media ban 'legally erroneous'
-
10 reported hurt after big Japan quake, warning of more tremors
-
Jimmy Kimmel extends late night contract for a year
-
Trump says US will allow sale of Nvidia AI chips to China
-
NBA fines Magic's Bane $35,000 for hurling ball at Anunoby
-
Pulisic quick-fire double sends AC Milan top of Serie A
-
Man Utd back on track after Fernandes inspires Wolves rout
-
Syria's Sharaa vows to promote coexistence, one year after Assad's ousting
-
World stocks mostly lower as markets await Fed decision
-
Palmer misses Chelsea's Champions League clash with Atalanta
-
Trump says Europe heading in 'bad directions'
-
Benin hunts soldiers behind failed coup
-
Salah a 'disgrace' for Liverpool outburst: Carragher
-
Peace deal at risk as DR Congo, Burundi slam Rwanda and M23 advances
-
Feminists outraged at video of French first lady's outburst against activists
-
Suspect arrested in theft of Matisse artworks in Brazil: officials
-
Troubled Liverpool host Barnsley in FA Cup third round
-
Slot has 'no clue' whether rebel star Salah has played last Liverpool game
-
Liverpool boss Slot says Salah relationship not broken
-
Powerful 7.6 quake strikes off Japan, tsunami warning lifted
-
100 abducted Nigerian children handed over to state officials
-
Lula orders road map to cut fossil-fuel use in Brazil
-
EU pushes back 2035 combustion-engine ban review to Dec. 16
-
Court will give decision in Sala compensation hearing on March 30
-
Mamdani to swap humble apartment for NY mayor's mansion
-
MSF says conditions for Gaza medics 'as hard as it's ever been' despite truce
-
Sala compensation hearing opens in Cardiff's dispute with Nantes
-
Syria's Sharaa vows to promote coexistence, reconciliation one year after Assad's ousting
-
Club Brugge sack coach in build up to Arsenal clash
-
US residents get free entry to national parks on Trump's birthday
US Justice Dept takes abortion pill fight to Supreme Court
The US Justice Department said Thursday that it will go to the Supreme Court to appeal restrictions imposed on a widely-used abortion pill in the latest round of an intensifying battle over reproductive rights.
The move by the administration of President Joe Biden came just hours after an appeals court blocked moves to ban mifepristone, but limited access to the drug used for more than half of the abortions in the United States.
"We will be seeking emergency relief from the Supreme Court... to protect Americans' access to safe and effective reproductive care," US Attorney General Merrick Garland said.
Speaking to reporters during Biden's visit to Dublin, Ireland, White House Press Secretary Karine Jean-Pierre said "we believe that the law is on our side, and we will prevail."
Late Wednesday, the US Fifth Circuit Court of Appeals said mifepristone should remain available for now, but limited access to the first seven weeks of pregnancy, down from 10.
The appeals court also said in-person visits would be necessary to obtain the pill -- a requirement lifted in recent years -- and blocked the medication from being sent by mail.
The 2-1 ruling by the conservative-majority federal appeals court in New Orleans, Louisiana, came after a US District Court judge in Texas overturned the Food and Drug Administration's two-decades old approval of the drug last Friday.
The appeals court ruling was denounced by Planned Parenthood, the ACLU, the Center for Reproductive Rights and other groups seeking to maintain access to abortion.
"We are furious that yet another court would choose to jeopardize the health and futures of the millions of people who rely on mifepristone for abortion care," said Planned Parenthood president Alexis McGill Johnson.
Jennifer Dalven, director of the ACLU Reproductive Freedom Project, said "unless the Supreme Court steps in, this decision will prevent many people from getting abortion care and force them to remain pregnant against their will."
- 'Win' -
The anti-abortion group Susan B. Anthony described the latest ruling by two judges appointed by former Republican president Donald Trump as a "win."
"The court recognized that the abortion pill is dangerous and rolled back Biden's reckless mail-order abortion scheme," said Susan B. Anthony state policy director Katie Daniel. "We look forward to the Supreme Court hearing this case."
The latest standoff over women's reproductive freedom in America comes almost a year after the conservative-dominated Supreme Court overturned the landmark Roe v. Wade ruling that had enshrined the constitutional right to abortion for half a century.
Mifepristone is one component of a two-drug regimen that can be used in the United States through the first 10 weeks of pregnancy.
It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.
Last week's ruling by Judge Matthew Kacsmaryk, also a Trump appointee, imposing a nationwide ban on mifepristone came in response to a suit by a coalition of anti-abortion groups.
The judge, in his decision, adopted language used by abortion opponents, referring to abortion providers as "abortionists" and saying the drug was used to "kill the unborn human."
Kacsmaryk said the two-drug regimen that includes mifepristone had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective when used as indicated.
Shortly after the initial Texas decision, a judge in Washington state ruled in a separate case that access to mifepristone must be preserved.
Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit access the procedure -- or ban it outright.
A.O.Scott--AT